Dierks Jeffrey
SEC CIK 1821102 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings, Inc. | Chief Commercial Off, Dir | 4,869 | — | $11.43M | 46 | 2021-08-26 | 2025-03-03 |
Most active insiders at HRMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Budur Kumar | Chief MEDICAL Off | — | $3.11M |
| 2 | Kapadia Sandip | CFO | — | $1.80M |
| 3 | Dayno Jeffrey M. | Pres, CEO, Dir | — | $1.04M |
| 4 | Zaeske Adam H. | Chief COMMERCIAL Off | — | — |
| 5 | Serafin Andrew | Chief STRATEGY Off | — | — |
Dierks Jeffrey made no open-market trades at HRMY in the last 12 months.
Transactions 46
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $8.22 | +4,869 | 4,869 | New | +$40.0K |
| DM | 2025-03-05 | 2025-03-03 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $32.67 | -4,869 | 500 | -91% | -$159.1K |
| DM | 2025-01-28 | 2025-01-24 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $25.47 | +15.8K | 2,687 | New | +$402.8K |
| DM | 2025-01-28 | 2025-01-24+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $37.38 | -14.8K | 0 | -100% | -$551.5K |
| D | 2025-01-28 | 2025-01-24 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | F - Tax | $38.01 | -1,058 | 1,629 | -39% | -$40.2K |
| DM | 2025-01-21 | 2025-01-16+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $33.44 | +30.6K | 1,123 | New | +$1.02M |
| DM | 2025-01-21 | 2025-01-16+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $37.51 | -30.6K | 0 | -100% | -$1.15M |
| D | 2025-01-16 | 2025-01-15 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $37.01 | -10.5K | 0 | -100% | -$388.9K |
| D | 2025-01-16 | 2025-01-15 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $33.44 | +10.5K | 10.5K | New | +$351.4K |
| D | 2025-01-15 | 2025-01-13 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $37.04 | -7,180 | 0 | -100% | -$265.9K |
| D | 2025-01-15 | 2025-01-13 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $33.44 | +7,180 | 7,180 | New | +$240.1K |
| D | 2024-10-31 | 2024-10-29 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $24.00 | +21.5K | 21.5K | New | +$515.9K |
| D | 2024-10-31 | 2024-10-29 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $40.47 | -21.5K | 0 | -100% | -$869.9K |
| M | 2024-10-07 | 2024-10-03 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale | $35.06 | -36.4K | 0 | -100% | -$1.27M |
| D | 2024-10-02 | 2024-10-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $24.00 | +400 | 400 | New | +$9,600 |
| D | 2024-10-02 | 2024-10-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $40.19 | -400 | 0 | -100% | -$16.1K |
| D | 2024-10-02 | 2024-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $0.00 | +60.0K | 60.0K | New | $0 |
| D | 2024-10-02 | 2024-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | F - Tax | $40.00 | -23.6K | 36.4K | -39% | -$945.7K |
| D | 2024-10-01 | 2024-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $24.00 | +35.8K | 35.8K | New | +$860.3K |
| D | 2024-10-01 | 2024-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $40.03 | -35.8K | 0 | -100% | -$1.43M |
| D | 2024-09-30 | 2024-09-27 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $24.00 | +200 | 200 | New | +$4,800 |
| D | 2024-09-30 | 2024-09-27 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $40.05 | -200 | 0 | -100% | -$8,010 |
| D | 2024-03-18 | 2024-03-15 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $8.22 | +12.0K | 12.0K | New | +$98.5K |
| D | 2024-03-18 | 2024-03-15 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $32.00 | -12.0K | 0 | -100% | -$383.3K |
| D | 2024-03-11 | 2024-03-08 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $32.00 | -194 | 0 | -100% | -$6,208 |
| D | 2024-03-11 | 2024-03-08 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $8.22 | +194 | 194 | New | +$1,595 |
| DM | 2022-10-04 | 2022-10-03 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $44.68 | -12.2K | 2,791 | -81% | -$543.9K |
| D | 2022-10-04 | 2022-10-03 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $8.22 | +12.2K | 12.2K | New | +$100.1K |
| D | 2022-08-23 | 2022-08-22 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | M - OptEx | $24.00 | +29.0K | 29.0K | New | +$695.3K |
| DM | 2022-08-23 | 2022-08-22 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief COMMERCIAL Off | S - Sale+OE | $47.00 | -29.0K | 2,321 | -93% | -$1.36M |
| DM | 2022-04-05 | 2022-04-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $49.63 | -14.5K | 7,706 | -65% | -$718.2K |
| D | 2022-04-05 | 2022-04-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $24.00 | +14.5K | 14.5K | New | +$347.3K |
| DM | 2022-03-02 | 2022-02-28+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $18.85 | +14.9K | 10.0K | New | +$281.0K |
| DM | 2022-03-02 | 2022-02-28+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $40.01 | -14.9K | 0 | -100% | -$596.6K |
| DM | 2022-02-18 | 2022-02-16+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $40.04 | -8,518 | 0 | -100% | -$341.0K |
| DM | 2022-02-18 | 2022-02-16+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $24.00 | +4,459 | 200 | New | +$107.0K |
| D | 2022-01-10 | 2022-01-06 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off, Dir | M - OptEx | $8.22 | +6,125 | 6,125 | New | +$50.3K |
| DM | 2022-01-10 | 2022-01-06 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off, Dir | S - Sale+OE | $40.37 | -6,125 | 424 | -94% | -$247.2K |
| DM | 2021-11-03 | 2021-11-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $41.68 | -10.0K | 0 | -100% | -$416.8K |
| D | 2021-11-03 | 2021-11-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $8.22 | +10.0K | 10.0K | New | +$82.2K |
| D | 2021-09-09 | 2021-09-07 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $8.22 | +5,000 | 5,000 | New | +$41.1K |
| D | 2021-09-09 | 2021-09-07 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $37.00 | -5,000 | 0 | -100% | -$185.0K |
| DM | 2021-09-03 | 2021-09-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $33.62 | -10.0K | 0 | -100% | -$336.2K |
| D | 2021-09-03 | 2021-09-01 | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $8.22 | +10.0K | 10.0K | New | +$82.2K |
| DM | 2021-08-30 | 2021-08-26+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $35.13 | -5,000 | 0 | -100% | -$175.6K |
| DM | 2021-08-30 | 2021-08-26+ | HRMY | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $8.22 | +5,000 | 1,600 | New | +$41.1K |
Purchase Sale Sale after option exercise All abbreviations